314 related articles for article (PubMed ID: 28477215)
1. Validating GWAS Variants from Microglial Genes Implicated in Alzheimer's Disease.
Dos Santos LR; Pimassoni LHS; Sena GGS; Camporez D; Belcavello L; Trancozo M; Morelato RL; Errera FIV; Bueno MRP; de Paula F
J Mol Neurosci; 2017 Jun; 62(2):215-221. PubMed ID: 28477215
[TBL] [Abstract][Full Text] [Related]
2. Updated Meta-Analysis of BIN1, CR1, MS4A6A, CLU, and ABCA7 Variants in Alzheimer's Disease.
Almeida JFF; Dos Santos LR; Trancozo M; de Paula F
J Mol Neurosci; 2018 Mar; 64(3):471-477. PubMed ID: 29504051
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants conferring susceptibility to Alzheimer's disease in the general population; do they also predispose to dementia in Down's syndrome.
Patel A; Rees SD; Kelly MA; Bain SC; Barnett AH; Prasher A; Arshad H; Prasher VP
BMC Res Notes; 2014 Jan; 7():42. PubMed ID: 24438528
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of late-onset Alzheimer disease genetic susceptibility risks in a Canadian population.
Omoumi A; Fok A; Greenwood T; Sadovnick AD; Feldman HH; Hsiung GY
Neurobiol Aging; 2014 Apr; 35(4):936.e5-12. PubMed ID: 24176626
[TBL] [Abstract][Full Text] [Related]
5. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
[TBL] [Abstract][Full Text] [Related]
6. Association of CD33 and MS4A cluster variants with Alzheimer's disease in East Asian populations.
Mao YF; Guo ZY; Pu JL; Chen YX; Zhang BR
Neurosci Lett; 2015 Nov; 609():235-9. PubMed ID: 26455864
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of CD33 and MS4A6A variant in Chinese Han population with Alzheimer's disease.
Deng YL; Liu LH; Wang Y; Tang HD; Ren RJ; Xu W; Ma JF; Wang LL; Zhuang JP; Wang G; Chen SD
Hum Genet; 2012 Jul; 131(7):1245-9. PubMed ID: 22382309
[TBL] [Abstract][Full Text] [Related]
8. CR1, ABCA7, and APOE genes affect the features of cognitive impairment in Alzheimer's disease.
Chung SJ; Kim MJ; Kim YJ; Kim J; You S; Jang EH; Kim SY; Lee JH
J Neurol Sci; 2014 Apr; 339(1-2):91-6. PubMed ID: 24530172
[TBL] [Abstract][Full Text] [Related]
9. Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains.
Karch CM; Jeng AT; Nowotny P; Cady J; Cruchaga C; Goate AM
PLoS One; 2012; 7(11):e50976. PubMed ID: 23226438
[TBL] [Abstract][Full Text] [Related]
10. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
Hollingworth P; Harold D; Sims R; Gerrish A; Lambert JC; Carrasquillo MM; Abraham R; Hamshere ML; Pahwa JS; Moskvina V; Dowzell K; Jones N; Stretton A; Thomas C; Richards A; Ivanov D; Widdowson C; Chapman J; Lovestone S; Powell J; Proitsi P; Lupton MK; Brayne C; Rubinsztein DC; Gill M; Lawlor B; Lynch A; Brown KS; Passmore PA; Craig D; McGuinness B; Todd S; Holmes C; Mann D; Smith AD; Beaumont H; Warden D; Wilcock G; Love S; Kehoe PG; Hooper NM; Vardy ER; Hardy J; Mead S; Fox NC; Rossor M; Collinge J; Maier W; Jessen F; Rüther E; Schürmann B; Heun R; Kölsch H; van den Bussche H; Heuser I; Kornhuber J; Wiltfang J; Dichgans M; Frölich L; Hampel H; Gallacher J; Hüll M; Rujescu D; Giegling I; Goate AM; Kauwe JS; Cruchaga C; Nowotny P; Morris JC; Mayo K; Sleegers K; Bettens K; Engelborghs S; De Deyn PP; Van Broeckhoven C; Livingston G; Bass NJ; Gurling H; McQuillin A; Gwilliam R; Deloukas P; Al-Chalabi A; Shaw CE; Tsolaki M; Singleton AB; Guerreiro R; Mühleisen TW; Nöthen MM; Moebus S; Jöckel KH; Klopp N; Wichmann HE; Pankratz VS; Sando SB; Aasly JO; Barcikowska M; Wszolek ZK; Dickson DW; Graff-Radford NR; Petersen RC; ; van Duijn CM; Breteler MM; Ikram MA; DeStefano AL; Fitzpatrick AL; Lopez O; Launer LJ; Seshadri S; ; Berr C; Campion D; Epelbaum J; Dartigues JF; Tzourio C; Alpérovitch A; Lathrop M; ; Feulner TM; Friedrich P; Riehle C; Krawczak M; Schreiber S; Mayhaus M; Nicolhaus S; Wagenpfeil S; Steinberg S; Stefansson H; Stefansson K; Snaedal J; Björnsson S; Jonsson PV; Chouraki V; Genier-Boley B; Hiltunen M; Soininen H; Combarros O; Zelenika D; Delepine M; Bullido MJ; Pasquier F; Mateo I; Frank-Garcia A; Porcellini E; Hanon O; Coto E; Alvarez V; Bosco P; Siciliano G; Mancuso M; Panza F; Solfrizzi V; Nacmias B; Sorbi S; Bossù P; Piccardi P; Arosio B; Annoni G; Seripa D; Pilotto A; Scarpini E; Galimberti D; Brice A; Hannequin D; Licastro F; Jones L; Holmans PA; Jonsson T; Riemenschneider M; Morgan K; Younkin SG; Owen MJ; O'Donovan M; Amouyel P; Williams J
Nat Genet; 2011 May; 43(5):429-35. PubMed ID: 21460840
[TBL] [Abstract][Full Text] [Related]
11. Microglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence Risk.
McQuade A; Blurton-Jones M
J Mol Biol; 2019 Apr; 431(9):1805-1817. PubMed ID: 30738892
[TBL] [Abstract][Full Text] [Related]
12. Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex.
Walker DG; Whetzel AM; Serrano G; Sue LI; Beach TG; Lue LF
Neurobiol Aging; 2015 Feb; 36(2):571-82. PubMed ID: 25448602
[TBL] [Abstract][Full Text] [Related]
13. Does the CD33 rs3865444 Polymorphism Confer Susceptibility to Alzheimer's Disease?
Siokas V; Aslanidou P; Aloizou AM; Peristeri E; Stamati P; Liampas I; Arseniou S; Drakoulis N; Aschner M; Tsatsakis A; Mitsias PD; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
J Mol Neurosci; 2020 Jun; 70(6):851-860. PubMed ID: 32088842
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta.
Griciuc A; Serrano-Pozo A; Parrado AR; Lesinski AN; Asselin CN; Mullin K; Hooli B; Choi SH; Hyman BT; Tanzi RE
Neuron; 2013 May; 78(4):631-43. PubMed ID: 23623698
[TBL] [Abstract][Full Text] [Related]
15. Associations Between Genetic Variants in 19p13 and 19q13 Regions and Susceptibility to Alzheimer Disease: A Meta-Analysis.
Bao J; Wang XJ; Mao ZF
Med Sci Monit; 2016 Jan; 22():234-43. PubMed ID: 26795201
[TBL] [Abstract][Full Text] [Related]
16. New genetic players in late-onset Alzheimer's disease: Findings of genome-wide association studies.
Misra A; Chakrabarti SS; Gambhir IS
Indian J Med Res; 2018 Aug; 148(2):135-144. PubMed ID: 30381536
[TBL] [Abstract][Full Text] [Related]
17. CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing.
Malik M; Simpson JF; Parikh I; Wilfred BR; Fardo DW; Nelson PT; Estus S
J Neurosci; 2013 Aug; 33(33):13320-5. PubMed ID: 23946390
[TBL] [Abstract][Full Text] [Related]
18. Association of GWAS-linked loci with late-onset Alzheimer's disease in a northern Han Chinese population.
Tan L; Yu JT; Zhang W; Wu ZC; Zhang Q; Liu QY; Wang W; Wang HF; Ma XY; Cui WZ
Alzheimers Dement; 2013 Sep; 9(5):546-53. PubMed ID: 23232270
[TBL] [Abstract][Full Text] [Related]
19. Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease.
Rodríguez-Rodríguez E; Sánchez-Juan P; Vázquez-Higuera JL; Mateo I; Pozueta A; Berciano J; Cervantes S; Alcolea D; Martínez-Lage P; Clarimón J; Lleó A; Pastor P; Combarros O
J Neural Transm (Vienna); 2013 May; 120(5):807-12. PubMed ID: 23180304
[TBL] [Abstract][Full Text] [Related]
20. CD33 in Alzheimer's disease.
Jiang T; Yu JT; Hu N; Tan MS; Zhu XC; Tan L
Mol Neurobiol; 2014 Feb; 49(1):529-35. PubMed ID: 23982747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
